MetLife Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.19M | Sell |
46,301
-1,202
| -3% | -$110K | 0.02% | 698 |
|
|
2025
Q4 | $4.27M | Sell |
47,503
-1,643
| -3% | -$156K | 0.02% | 696 |
|
|
2025
Q3 | $4.84M | Sell |
49,146
-1,266
| -3% | -$125K | 0.02% | 649 |
|
|
2025
Q2 | $4.6M | Sell |
50,412
-1,273
| -2% | -$123K | 0.03% | 610 |
|
|
2025
Q1 | $5.85M | Sell |
51,685
-986
| -2% | -$105K | 0.03% | 539 |
|
|
2024
Q4 | $5.56M | Sell |
52,671
-296
| -0.6% | -$31.8K | 0.03% | 494 |
|
|
2024
Q3 | $5.72M | Sell |
52,967
-1,880
| -3% | -$205K | 0.03% | 456 |
|
|
2024
Q2 | $5.95M | Buy |
54,847
+5,898
| +12% | +$695K | 0.04% | 411 |
|
|
2024
Q1 | $6.46M | Sell |
48,949
-1,799
| -4% | -$225K | 0.04% | 375 |
|
|
2023
Q4 | $6.18M | Sell |
50,748
-956
| -2% | -$107K | 0.04% | 354 |
|
|
2023
Q3 | $5.8M | Sell |
51,704
-1,260
| -2% | -$160K | 0.05% | 349 |
|
|
2023
Q2 | $7.71M | Sell |
52,964
-1,188
| -2% | -$161K | 0.06% | 281 |
|
|
2023
Q1 | $7M | Sell |
54,152
-649
| -1% | -$81.5K | 0.05% | 303 |
|
|
2022
Q4 | $6.99M | Sell |
54,801
-890
| -2% | -$103K | 0.05% | 300 |
|
|
2022
Q3 | $5.82M | Sell |
55,691
-769
| -1% | -$84.4K | 0.05% | 342 |
|
|
2022
Q2 | $5.93M | Sell |
56,460
-378
| -0.7% | -$44.8K | 0.05% | 344 |
|
|
2022
Q1 | $7.27M | Buy |
56,838
+9,298
| +20% | +$1.12M | 0.05% | 337 |
|
|
2021
Q4 | $5.86M | Sell |
47,540
-1,043
| -2% | -$137K | 0.05% | 331 |
|
|
2021
Q3 | $6.9M | Sell |
48,583
-1,202
| -2% | -$177K | 0.06% | 262 |
|
|
2021
Q2 | $7.77M | Sell |
49,785
-1,232
| -2% | -$200K | 0.07% | 239 |
|
|
2021
Q1 | $7.93M | Sell |
51,017
-831
| -2% | -$129K | 0.07% | 237 |
|
|
2020
Q4 | $7.76M | Sell |
51,848
-2,223
| -4% | -$314K | 0.07% | 229 |
|
|
2020
Q3 | $7.15M | Sell |
54,071
-1,638
| -3% | -$214K | 0.08% | 214 |
|
|
2020
Q2 | $6.46M | Buy |
55,709
+1,101
| +2% | +$127K | 0.07% | 234 |
|
|
2020
Q1 | $5.36M | Sell |
54,608
-1,671
| -3% | -$219K | 0.07% | 231 |
|
|
2019
Q4 | $8.18M | Sell |
56,279
-1,271
| -2% | -$175K | 0.09% | 208 |
|
|
2019
Q3 | $7.67M | Sell |
57,550
-594
| -1% | -$76.7K | 0.08% | 215 |
|
|
2019
Q2 | $6.65M | Sell |
58,144
-1,711
| -3% | -$200K | 0.07% | 253 |
|
|
2019
Q1 | $7.42M | Sell |
59,855
-228
| -0.4% | -$25.9K | 0.08% | 216 |
|
|
2018
Q4 | $6.05M | Sell |
60,083
-888
| -1% | -$99.9K | 0.07% | 237 |
|
|
2018
Q3 | $7.78M | Sell |
60,971
-662
| -1% | -$78.7K | 0.08% | 215 |
|
|
2018
Q2 | $6.67M | Sell |
61,633
-1,336
| -2% | -$145K | 0.08% | 224 |
|
|
2018
Q1 | $6.67M | Sell |
62,969
-1,557
| -2% | -$181K | 0.08% | 231 |
|
|
2017
Q4 | $7.56M | Buy |
+64,526
| New | +$7.3M | 0.09% | 215 |
|
Other funds holding ZBH
VCM
VPM
MetLife Investment Management's ZBH Position: Q1 2026 in Review
MetLife Investment Management reduced its Zimmer Biomet (ZBH) stake by 2.5% in Q1 2026, selling an estimated $110K and leaving 46,301 shares worth $4.19M. The position accounts for 0.02% of the portfolio, ranked #698.
MetLife Investment Management first reported a position in ZBH in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.18M in Q4 2019. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- MetLife Investment Management held 46,301 shares of Zimmer Biomet worth $4.19M as of Q1 2026.
- MetLife Investment Management sold 1,202 Zimmer Biomet shares in Q1 2026, an estimated $110K.
- Zimmer Biomet made up 0.02% of MetLife Investment Management's portfolio in Q1 2026, its #698 holding.
- MetLife Investment Management first reported a position in Zimmer Biomet in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Zimmer Biomet position peaked at $8.18M in Q4 2019.
- 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.